Journal of International Society for Simulation Surgery

International Society for Simulation Surgery (국제컴퓨터가상수술학회)
권호 표지
DOI QR코드

DOI QR Code

Development of Dual-Arm Anticancer Drug Compounding Robot and Preparation System with Adaptability and High-Speed

  • Received : 2016.11.28
  • Accepted : 2016.12.02
  • Published : 2016.12.10
Download PDF
⟨ Previous Next ⟩

Abstract

Aim Robots are able to increase safety for pharmacy staff as separating from toxicity of anti-cancer drugs. For patient safety, it would provide right dose of the drugs. Additionally, it can reduce price of the drugs. Therefore, in this study, a novel compounding anticancer drugs robot system (Dupalro) was developed. Methods We used the robot system, Motoman dual-arm robot from YASKAWA, Japan and medications which are adapted for the robot were constructed. In order to develop a process of compounding anticancer drugs, information about five medications that are required to make anticancer drugs in hospitals was used. Results System for the five types of medications was constructed, and relating procedures for anticancer drugs compounding robot were developed. Conclusion Dupalro successfully was able to not only provide incremental safety and efficiency for both patients and pharmacy staff, but also decrease price of anticancer drugs.

Keywords

References

  1. Yoshida J, Tei G, Mochizuki C, Masu Y, Koda S, Kumagai S. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. The Annals of occupational hygiene 2009;53:153-160
  2. Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA: a cancer journal for clinicians 2006;56:354-365 https://doi.org/10.3322/canjclin.56.6.354
  3. Power LA. Hazardous drugs as compounded sterile preparations. Compounding Sterile Preparations 2009:79
  4. Nurgat Z, Faris D, Mominah M, Vibar A, Al-Jazairi A, Ewing S et al. A three-year study of a first-generation chemotherapy-compounding robot. American Journal of Health-System Pharmacy 2015;72:1036-1045 https://doi.org/10.2146/ajhp140256
  5. National cancer center. In. National Cancer Center, 2016
  6. Howard DH, Bach PB, Berndt ER, Conti RM. Pricing in the market for anticancer drugs. Journal of Economic Perspectives 2015;29: 139-162 https://doi.org/10.1257/jep.29.1.139
  7. Schrag D, Hanger M. Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey. Journal of Clinical Oncology 2007;25:233-237 https://doi.org/10.1200/JCO.2006.09.2437
  8. Tong WH, van der Sluis IM, Alleman C, van Litsenburg RR, Kaspers G, Pieters R et al. Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: The impact of expensive chemotherapy. haematologica 2013:haematol. 2012.073510
  9. Seger A, Churchill W, Keohane C. Impact of robotic antineoplastic preparation on safety, workflow, and costs. J Oncol Pract 2012;8(6): 344-349. Doi: 10.1200.JOP 2012;1 https://doi.org/10.1200/JOP.2012.000600
  10. Martin S, Beach L. The adverse health effects of occupational exposure to hazardous drugs. Community Oncology 2005;2:397-400 https://doi.org/10.1016/S1548-5315(11)70612-X
  11. Kriheli M, Eric S-T, Daskal G. Robotic system for compounding medication. In: Google Patents, 2014
  12. Rich D, Fricker Jr M, Cohen M, Levine S. Guidelines for the safe preparation of sterile compounds: Results of the ismp sterile preparation compounding safety summit of october 2011. Hospital Pharmacy 2013;48:282-294 https://doi.org/10.1310/hpj4804-282
  13. Bar-Shalom D. The challenge of automated compounding. InPediatric formulations: Springer, 2014:181-191.